Gastrointestinal manifestations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patient: major effect on treatment and prognosis.
Taieb AchBen Yamna HadamiNadia GharianiRanda Said ElMabroukAsma Ben AbdelkrimMaha KacemMohamed DenguezliKoussay AchPublished in: Endocrinology, diabetes & metabolism case reports (2023)
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare autosomal recessive inherited syndrome caused by mutations in the autoimmune regulator (AIRE) gene. The three clinical components of this syndrome that appear in early childhood are mucocutaneous candidiasis, hypoparathyroidism, and primary adrenal insufficiency. In addition to these frequent symptoms, many other components have been reported including gastrointestinal manifestations like atrophic gastritis. They can be caused by many abnormalities including atrophic gastritis and the modification of intestinal biofilm and microbiota. Early diagnosis and treatment of gastrointestinal manifestations associated with APECED prevent multiple life-threatening consequences like acute adrenal crisis and severe symptomatic hypocalcemia.
Keyphrases
- candida albicans
- drug induced
- helicobacter pylori
- case report
- multiple sclerosis
- early onset
- helicobacter pylori infection
- biofilm formation
- staphylococcus aureus
- pseudomonas aeruginosa
- liver failure
- transcription factor
- copy number
- respiratory failure
- depressive symptoms
- intensive care unit
- physical activity
- dna methylation
- genome wide identification